Slimming the heart with bariatric surgery.
Slimming the heart with bariatric surgery.
复制标题
通过减肥手术来减肥。
DOI：
10.1016/j.jacc.2012.10.045
复制
发表时间：
2013
影响因子：
24
通讯作者：
Taegtmeyer,Heinrich
中科院分区：
文献类型：
--
作者：
Khalaf,KhaledImad;Taegtmeyer,Heinrich
2. Taylor EN，Hu FB，Curhan GC.抗高血压药物与2型糖尿病发病风险糖尿病护理2006; 29：1065-70. 3. Mancia G，Grassi G，Zanchetti A.新发糖尿病与抗高血压药物。高血压病杂志2006; 24：3-10. 4.沃茨DD，Ho JE，DeMicco DA等人，阿托伐他汀治疗患者新发糖尿病的预测因素：来自3项大型随机临床试验的结果。美国科尔心脏病学杂志2011; 57：1535-45。5. Ridker PM，Pradhan A，MacFadyen JG，Libby P，Glynn RJ.一级预防中他汀类药物治疗的心血管获益和糖尿病风险：来自JUPITER试验的分析柳叶刀2012; 380：565-71。
2. Taylor EN, Hu FB, Curhan GC. Antihypertensive medications and the risk of incident type 2 diabetes. Diabetes Care 2006; 29: 1065–70. 3. Mancia G, Grassi G, Zanchetti A. New-onset diabetes and antihypertensive drugs. J Hypertens 2006; 24: 3–10. 4. Waters DD, Ho JE, DeMicco DA, et al. Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials. J Am Coll Cardiol 2011; 57: 1535–45. 5. Ridker PM, Pradhan A, MacFadyen JG, Libby P, Glynn RJ. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet 2012; 380: 565–71.